18 Platelet transfusion remains the mainstay of treatment for perioperative thrombocytopenia, but can be ineffective in specified populations, carry all of the pitfalls of blood products transfusion, and so are a scarce resource.19 With effective TPO-RA treatment, people with identified thrombocytopenia undergoing elective procedures could endure pharmacologic platelet count optimization https://orellanine11098.blogadvize.com/33036705/an-unbiased-view-of-u0126-etoh